Medicare Enrolled
Dr. Lorraine Lira, M.D.
Neurology · Westwood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lira?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lira
Dr. Lorraine Lira is a neurology specialist in Westwood, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lira performed 644 Medicare services across 441 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lira received a total of $12,247 from 67 pharmaceutical and/or device companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lira is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 50% volume in NJ
$12,247 industry payments
Medicare Practice Summary
Medicare Utilization ↗644
Medicare services
Top 50% in NJ for neurology
441
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $96 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $68 | $170 |
| New patient office visit, complex (60-74 min) | 53 | $175 | $420 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
46 | $87 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $156 | $274 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
27 | $412 | $700 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $139 | $360 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $189 | $400 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
12 | $39 | $250 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $150 | $400 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
12 | $28 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
11 | $32 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,247
Total received (2018-2024)
Avg $1,750/year across 7 years
Top 22% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
816
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,220 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,818
2023
$1,670
2022
$2,192
2021
$1,703
2020
$1,369
2019
$1,483
2018
$2,012
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$572
ABBVIE INC.
$250
MDD US Operations, LLC
$230
PFIZER INC.
$143
Lundbeck LLC
$100
SK Life Science, Inc.
$98
Kyowa Kirin, Inc.
$89
Otsuka America Pharmaceutical, Inc.
$79
Neurocrine Biosciences, Inc.
$47
UCB, Inc.
$43
GE HEALTHCARE
$39
Eisai Inc.
$37
Lilly USA, LLC
$34
Novartis Pharmaceuticals Corporation
$28
ARGENX US, INC.
$14
ACADIA Pharmaceuticals Inc
$14
Top 3 companies account for 57.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$3,768
ABBVIE INC.
$615
Novartis Pharmaceuticals Corporation
$433
Neurocrine Biosciences, Inc.
$360
Biohaven Pharmaceuticals, Inc.
$336
US WorldMeds, LLC
$328
MDD US Operations, LLC
$302
Avanir Pharmaceuticals, Inc.
$288
Lundbeck LLC
$286
Adamas Pharmaceuticals, Inc.
$281
Biogen, Inc.
$273
EMD Serono, Inc.
$263
Celgene Corporation
$258
PFIZER INC.
$255
UCB, Inc.
$250
Allergan, Inc.
$226
Kyowa Kirin, Inc.
$219
Lilly USA, LLC
$218
Amgen Inc.
$208
SK Life Science, Inc.
$192
Genentech USA, Inc.
$173
Biohaven Pharmaceutical Holding Company Ltd.
$168
Eisai Inc.
$163
Acorda Therapeutics, Inc
$146
ARGENX US, INC.
$129
Allergan Inc.
$121
Otsuka America Pharmaceutical, Inc.
$112
ARBOR PHARMACEUTICALS, INC.
$111
UPSHER-SMITH LABORATORIES LLC
$106
GE HEALTHCARE
$93
EISAI INC.
$86
Amneal Pharmaceuticals LLC
$86
GENZYME CORPORATION
$82
ACADIA Pharmaceuticals Inc
$81
CATALYST PHARMACEUTICALS, INC.
$76
Janssen Pharmaceuticals, Inc
$73
AbbVie Inc.
$69
Avion Pharmaceuticals
$69
GE HealthCare
$64
GE Healthcare
$61
Bayer HealthCare Pharmaceuticals Inc.
$60
Supernus Pharmaceuticals, Inc.
$56
Alexion Pharmaceuticals, Inc.
$55
Mallinckrodt Hospital Products Inc.
$54
Upsher-Smith Laboratories LLC
$52
Impax Laboratories, Inc.
$43
Sunovion Pharmaceuticals Inc.
$38
Vertical Pharmaceuticals, LLC
$38
Assertio Therapeutics, Inc.
$35
Merz Pharmaceuticals, LLC
$34
TG THERAPEUTICS, INC.
$33
E.R. Squibb & Sons, L.L.C.
$32
Scilex Pharmaceuticals Inc.
$30
Catalyst Pharmaceuticals, Inc.
$30
Currax Pharmaceuticals LLC
$30
AbbVie, Inc.
$28
Neurelis, Inc.
$26
INSIGHTEC,INC
$25
Boston Scientific Corporation
$18
Azurity Pharmaceuticals, Inc.
$15
Grifols USA, LLC
$15
SCILEX PHARMACEUTICALS INC.
$14
ASSERTIO THERAPEUTICS, Inc.
$13
LivaNova USA, Inc.
$13
Egalet US Inc
$12
Aprecia Pharmaceuticals, LLC
$11
Abbott Laboratories
$11
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · Cambia · Dhivy · Duopa · EMGALITY · Enspryng · Eprontia · Exablate · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Gralise · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONZETRA XSAIL · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · Ozanimod · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELEXXII · REXULTI · REYVOW · RYTARY · Rebif · SOLIRIS · SPRIX · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XADAGO · XCOPRI · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,135
Per 100K population
118.9
County median income
$123,715
Nearest hospital
HACKENSACK MERIDIAN HEALTH PASCACK VALLEY MEDICAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lira is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lira experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lira performed 316 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lira receive payments from pharmaceutical companies?
Yes. Dr. Lira received a total of $12,247 from 67 companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lira's costs compare to other neurologists in Westwood?
Dr. Lira's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Westwood
Browse neurologists in Westwood ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology